Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse

British Journal of Dermatology

Volumn 175, Issue 3, 2016, Pages 531-541

  Bertolini, M ^a   Pretzlaff, M ^b   Sulk, M ^a   Bahr M ^b   Gherardini, J ^a   Uchida, Y ^a,c   Reibelt, M ^b   Kinori, M ^d   Rossi, A ^e   Biro T ^f   Paus, R ^a,g  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d SHEBA MEDICAL CENTER   (Israel)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF DEBRECEN   (Hungary)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ALOPECIA AREATA; ARTICLE; CONTROLLED STUDY; EPITHELIUM; HAIR FOLLICLE; HAIR ROOT; HUMAN; HUMAN TISSUE; IMMUNE PRIVILEGE; IMMUNE RESPONSE; IMMUNOHISTOLOGY; IMMUNOHISTOMORPHOMETRY; IN VITRO STUDY; MORPHOMETRICS; NERVE FIBER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCALP HAIR;

EID: 84987814942     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14645     Document Type: Article

References (52)

1. McElwee KJ, Gilhar A, Tobin DJ et al. What causes alopecia areata? Exp Dermatol 2013; 22:609–26.
2. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med 2012; 366:1515–25.
3. Paus R, Nickoloff BJ, Ito T. A ‘hairy’ privilege. Trends Immunol 2005; 26:32–40.
4. Ito T, Ito N, Bettermann A et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004; 164:623–34.
5. Christoph T, Müller-Röver S, Audring H et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000; 142:862–73.
6. Meyer KC, Bodó E, Brzoska T et al. Immunomodulatory effects of the alpha-melanocyte-stimulating hormone-related tripeptide K(D)PT on human scalp hair follicles under proinflammatory conditions. Br J Dermatol 2009; 161:1400–3.
7. Kinori M, Bertolini M, Funk W et al. Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-γ-induced collapse of human hair follicle immune privilege. Exp Dermatol 2012; 21:223–6.
8. Siebenhaar F, Sharov AA, Peters EMJ et al. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 2007; 127:1489–97.
9. Peters EMJ, Liotiri S, Bodó E et al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 2007; 171:1872–86.
10. Chandrasekharan B, Nezami BG, Srinivasan S. Emerging neuropeptide targets in inflammation: NPY and VIP. Am J Physiol Gastrointest Liver Physiol 2013; 304:G949–57.
11. Lotti T, D'Erme AM, Hercogová J. The role of neuropeptides in the control of regional immunity. Clin Dermatol 2014; 32:633–45.
12. Mathioudakis A, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis G. Vasoactive intestinal peptide inhaled agonists: potential role in respiratory therapeutics. Hippokratia 2013; 17:12–16.
13. Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007; 7:52–63.
14. Kinori M, Kloepper JE, Paus R. Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? Invest Ophthalmol Vis Sci 2011; 52:4447–58.
15. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol 1994; 153:1080–6.
16. Jiang X, McClellan SA, Barrett RP et al. The role of VIP in cornea. Invest Ophthalmol Vis Sci 2012; 53:7560–6.
17. Koh S-W, Rutzen A, Coll T et al. VIP immunoreactivity in human aqueous humor. Curr Eye Res 2005; 30:189–94.
18. Taylor AW. Neuroimmunomodulation and immune privilege: the role of neuropeptides in ocular immunosuppression. NeuroImmunoModulation 2002; 10:189–98.
19. Cheng-Chew SB, Leung PY. Localisation of VIP-and CGRP-like substances in the skin and sinus hair follicles of various mammalian species. Histochem Cell Biol 1996; 105:443–52.
20. Hartschuh W, Reinecke M, Weihe E, Yanaihara N. VIP-immunoreactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and Merkel cells. Peptides 1984; 5:239–45.
21. Hartschuh W, Weihe E, Yanaihara N, Reinecke M. Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell. J Invest Dermatol 1983; 81:361–4.
22. Schulze E, Witt M, Fink T et al. Immunohistochemical detection of human skin nerve fibers. Acta Histochem 1997; 99:301–9.
23. Lundeberg L, Nordlind K. Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study. Arch Dermatol Res 1999; 291:201–6.
24. Nolano M, Provitera V, Caporaso G et al. Cutaneous innervation of the human face as assessed by skin biopsy. J Anat 2013; 222:161–9.
25. Kloepper JE, Sugawara K, Al-Nuaimi Y et al. Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture. Exp Dermatol 2010; 19:305–12.
26. Lebonvallet N, Boulais N, Le Gall C et al. Effects of the re-innervation of organotypic skin explants on the epidermis. Exp Dermatol 2012; 21:156–8.
27. + T-cells may contribute to the pathogenesis of alopecia areata. PLoS ONE 2014; 9:e94260.
28. Schulz S, Röcken C, Mawrin C et al. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin Cancer Res 2004; 10:8235–42.
29. Tilling T, Wladykowski E, Failla AV et al. Immunohistochemical analyses point to epidermal origin of human Merkel cells. Histochem Cell Biol 2014; 141:407–21.
30. Taira K, Narisawa Y, Nakafusa J et al. Spatial relationship between Merkel cells and Langerhans cells in human hair follicles. J Dermatol Sci 2002; 30:195–204.
31. Boulais N, Pereira U, Lebonvallet N et al. Merkel cells as putative regulatory cells in skin disorders: an in vitro study. PLoS ONE 2009; 4:e6528.
32. Maksimovic S, Baba Y, Lumpkin EA. Neurotransmitters and synaptic components in the Merkel cell-neurite complex, a gentle-touch receptor. Ann N Y Acad Sci 2013; 1279:13–21.
33. Fischer TC, Hartmann P, Löser C et al. Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. J Invest Dermatol 2001; 117:754–6.
34. Fischer TC, Dinh QT, Peiser C et al. Simultaneous detection of receptor mRNA and ligand protein in human skin tissues. J Cutan Pathol 2002; 29:65–71.
35. Wollina U, Paus R, Feldrappe S. Sequential expression of glutathione-S-transferase isoenzymes during hair growth phases in mice and their relationship to caldesmon, phosphotyrosinase and VIP receptor protein. Histol Histopathol 1995; 10:39–45.
36. Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids 2013; 45:25–39.
37. Kulka M, Sheen CH, Tancowny BP et al. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123:398–410.
38. Seeliger S, Buddenkotte J, Schmidt-Choudhury A et al. Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol 2010; 177:2563–75.
39. Edamura M, Murakami G, Meng H et al. Functional deficiency of MHC class I enhances LTP and abolishes LTD in the nucleus accumbens of mice. PLoS ONE 2014; 9:e107099.
40. Chiou S-J, Chen C-H. Decipher β2-microglobulin: gain- or loss-of-function (a mini-review). Med Sci Monit Basic Res 2013; 19:271–3.
41. York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996; 14:369–96.
42. Castellana D, Paus R, Perez-Moreno M. Macrophages contribute to the cyclic activation of adult hair follicle stem cells. PLoS Biol 2014; 12:e1002002.
43. Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol 2014; 14:719–30.
44. Fu H, Kishore M, Gittens B et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun 2014; 5:3436.
45. Card CM, Yu SS, Swartz MA. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J Clin Invest 2014; 124:943–52.
46. Streilein JW, Okamoto S, Sano Y, Taylor AW. Neural control of ocular immune privilege. Ann N Y Acad Sci 2000; 917:297–306.
47. Toyoda M, Makino T, Kagoura M, Morohashi M. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 2001; 144:46–54.
48. Wollman Y, Blumberg S, Spungin A et al. The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase. Regul Pept 2002; 108:175–7.
49. Kakurai M, Fujita N, Murata S et al. Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Invest Dermatol 2001; 116:743–9.
50. Chignard N, Mergey M, Barbu V et al. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium. Hepatology 2005; 42:549–57.
51. Waschek JA, Muller JM, Duan DS, Sadée W. Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. FEBS Lett 1989; 250:611–14.
52. Hordinsky M, Ericson M, Snow D et al. Peribulbar innervation and substance P expression following nonpermanent injury to the human scalp hair follicle. J Investig Dermatol Symp Proc 1999; 4:316–19.